Nelson Sun Buys 10,000 Shares of Aardvark Therapeutics, Inc. (NASDAQ:AARD) Stock

Aardvark Therapeutics, Inc. (NASDAQ:AARD) CFO Nelson Sun acquired 10,000 shares of Aardvark Therapeutics stock in a transaction on Friday, February 14th. The shares were bought at an average cost of $16.00 per share, with a total value of $160,000.00. Following the completion of the purchase, the chief financial officer now owns 99,484 shares in the company, valued at $1,591,744. The trade was a 11.18 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

Aardvark Therapeutics Price Performance

Shares of NASDAQ:AARD traded up $1.34 during trading on Wednesday, reaching $14.90. The company had a trading volume of 166,154 shares, compared to its average volume of 176,008. Aardvark Therapeutics, Inc. has a fifty-two week low of $11.55 and a fifty-two week high of $16.48.

About Aardvark Therapeutics

We are a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. We target biological pathways associated with alleviating hunger that we believe have the potential to deliver transformative outcomes for patients.